Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SELINEXOR for Nephroblastoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where SELINEXOR was used for Nephroblastoma.

Most Reported Side Effects for SELINEXOR

Side Effect Reports % Deaths Hosp.
Nausea 2,372 31.8% 280 559
Fatigue 1,795 24.1% 195 424
Decreased appetite 1,290 17.3% 169 348
Diarrhoea 1,190 16.0% 151 344
Plasma cell myeloma 1,046 14.0% 202 220
Vomiting 860 11.5% 107 243
Asthenia 794 10.7% 100 267
Death 761 10.2% 756 203
Thrombocytopenia 692 9.3% 125 202
Platelet count decreased 610 8.2% 83 210
Weight decreased 599 8.0% 80 147
Pneumonia 422 5.7% 126 343
Anaemia 420 5.6% 83 177
Dizziness 412 5.5% 33 98
Off label use 412 5.5% 64 85

Other Indications for SELINEXOR

Plasma cell myeloma (5,659) Product used for unknown indication (380) Diffuse large b-cell lymphoma (373) Plasma cell myeloma refractory (165) Brain neoplasm malignant (136) Acute myeloid leukaemia (60) Glioblastoma (54) Dedifferentiated liposarcoma (32) Malignant neoplasm of unknown primary site (30) Plasma cell myeloma recurrent (28)

Other Drugs Used for Nephroblastoma

VINCRISTINE (375) DOXORUBICIN (345) ETOPOSIDE (286) DACTINOMYCIN (278) CARBOPLATIN (228) CYCLOPHOSPHAMIDE (217) IRINOTECAN (104) IFOSFAMIDE (100) MELPHALAN (36) TOPOTECAN\TOPOTECAN (28)

Related Pages

SELINEXOR Full Profile All Nephroblastoma Drugs SELINEXOR Demographics SELINEXOR Timeline